Protagonist Therapeutics Insider Buying: Director Lewis Buys 18K Shares at $10.84, 8% Below Market—Signal of Confidence?
Insider buying at Protagonist Therapeutics shows confidence in its peptide drug pipeline and hints at a potential price rally ahead.
- Protagonist Therapeutics Inc
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read